FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140901292> ?p ?o ?g. }

• W2140901292 endingPage "585" @default.
• W2140901292 startingPage "575" @default.
• W2140901292 abstract "Abstract Atovaquone ( ATO ) and proguanil hydrochloride ( PROG ) is the fixed combination for the prevention and treatment of Plasmodium falciparum malaria. As safe and effective antimalarial drugs are needed in both the treatment and the prophylaxis of malaria, this study was performed to investigate their possible cyto/genotoxic potential towards human lymphocytes and the possible mechanism responsible for it. Two different concentrations of ATO and PROG were used with and without S9 metabolic activation. The concentrations used were those found in human plasma when a fixed‐dose combination of ATO and PROG was used: 2950/130 ng/mL after prophylactic treatment and 11 800/520 ng/mL after treatment of malaria, respectively. Possible cellular and DNA ‐damaging effects were evaluated by cell viability and alkaline comet assays, while oxidative stress potential was evaluated by formamidopyrimidine‐ DNA glycosylase (Fpg)‐modified comet assay, in addition to measuring malondialdehyde and glutathione levels. According to our results, the ATO / PROG combination displayed only weak cyto/genotoxic potential towards human lymphocytes with no impact on oxidative stress parameters, suggesting that oxidative stress is not implicated in their mechanism of action towards human lymphocytes. Given that the key portion of the damaging effects was induced after S9 metabolic activation, it is to presume that the principal metabolite of PROG , cycloguanil, had the greatest impact. The obtained results indicate that the ATO / PROG combination is relatively safe for the consumption from the aspect of cyto/genotoxicity, especially if used for prophylactic treatment. Nevertheless, further cytogenetic research and regular patient monitoring are needed to minimize the risk of adverse events especially among frequent travellers." @default.
• W2140901292 created "2016-06-24" @default.
• W2140901292 creator A5042755816 @default.
• W2140901292 creator A5061305415 @default.
• W2140901292 creator A5065801147 @default.
• W2140901292 creator A5076512232 @default.
• W2140901292 date "2015-10-05" @default.
• W2140901292 modified "2023-10-05" @default.
• W2140901292 title "Cytogenetic and oxidative status of human lymphocytes after exposure to clinically relevant concentrations of antimalarial drugs atovaquone and proguanil hydrochloride in vitro" @default.
• W2140901292 cites W1521679247 @default.
• W2140901292 cites W175899902 @default.
• W2140901292 cites W1830888562 @default.
• W2140901292 cites W1849792329 @default.
• W2140901292 cites W1965281971 @default.
• W2140901292 cites W1967383104 @default.
• W2140901292 cites W1974282970 @default.
• W2140901292 cites W1983480912 @default.
• W2140901292 cites W1991798321 @default.
• W2140901292 cites W1993380206 @default.
• W2140901292 cites W2001241786 @default.
• W2140901292 cites W2002869829 @default.
• W2140901292 cites W2002886146 @default.
• W2140901292 cites W2006231962 @default.
• W2140901292 cites W2023969818 @default.
• W2140901292 cites W2027448635 @default.
• W2140901292 cites W2029196359 @default.
• W2140901292 cites W2031796122 @default.
• W2140901292 cites W2033801149 @default.
• W2140901292 cites W2036537237 @default.
• W2140901292 cites W2038522569 @default.
• W2140901292 cites W2047232558 @default.
• W2140901292 cites W2058900833 @default.
• W2140901292 cites W2059702118 @default.
• W2140901292 cites W2064375318 @default.
• W2140901292 cites W2068125083 @default.
• W2140901292 cites W2069862790 @default.
• W2140901292 cites W2071478927 @default.
• W2140901292 cites W2072689861 @default.
• W2140901292 cites W2076329739 @default.
• W2140901292 cites W2079506124 @default.
• W2140901292 cites W2083806934 @default.
• W2140901292 cites W2085895144 @default.
• W2140901292 cites W2088181007 @default.
• W2140901292 cites W2092629964 @default.
• W2140901292 cites W2102727322 @default.
• W2140901292 cites W2116289525 @default.
• W2140901292 cites W2125208122 @default.
• W2140901292 cites W2125289626 @default.
• W2140901292 cites W2126902508 @default.
• W2140901292 cites W2128000049 @default.
• W2140901292 cites W2137632463 @default.
• W2140901292 cites W2138488546 @default.
• W2140901292 cites W2141630834 @default.
• W2140901292 cites W2143252862 @default.
• W2140901292 cites W2155570001 @default.
• W2140901292 cites W2156465764 @default.
• W2140901292 cites W2171879046 @default.
• W2140901292 cites W2344075384 @default.
• W2140901292 cites W58095473 @default.
• W2140901292 cites W99853137 @default.
• W2140901292 doi "https://doi.org/10.1111/fcp.12153" @default.
• W2140901292 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26434663" @default.
• W2140901292 hasPublicationYear "2015" @default.
• W2140901292 type Work @default.
• W2140901292 sameAs 2140901292 @default.
• W2140901292 citedByCount "2" @default.
• W2140901292 countsByYear W21409012922018 @default.
• W2140901292 countsByYear W21409012922019 @default.
• W2140901292 crossrefType "journal-article" @default.
• W2140901292 hasAuthorship W2140901292A5042755816 @default.
• W2140901292 hasAuthorship W2140901292A5061305415 @default.
• W2140901292 hasAuthorship W2140901292A5065801147 @default.
• W2140901292 hasAuthorship W2140901292A5076512232 @default.
• W2140901292 hasConcept C143425029 @default.
• W2140901292 hasConcept C178790620 @default.
• W2140901292 hasConcept C185592680 @default.
• W2140901292 hasConcept C203014093 @default.
• W2140901292 hasConcept C2776151105 @default.
• W2140901292 hasConcept C2778048844 @default.
• W2140901292 hasConcept C2778371730 @default.
• W2140901292 hasConcept C2778959862 @default.
• W2140901292 hasConcept C2779124865 @default.
• W2140901292 hasConcept C2779636613 @default.
• W2140901292 hasConcept C2780358455 @default.
• W2140901292 hasConcept C29730261 @default.
• W2140901292 hasConcept C552990157 @default.
• W2140901292 hasConcept C55493867 @default.
• W2140901292 hasConcept C86803240 @default.
• W2140901292 hasConcept C98274493 @default.
• W2140901292 hasConceptScore W2140901292C143425029 @default.
• W2140901292 hasConceptScore W2140901292C178790620 @default.
• W2140901292 hasConceptScore W2140901292C185592680 @default.
• W2140901292 hasConceptScore W2140901292C203014093 @default.
• W2140901292 hasConceptScore W2140901292C2776151105 @default.
• W2140901292 hasConceptScore W2140901292C2778048844 @default.
• W2140901292 hasConceptScore W2140901292C2778371730 @default.
• W2140901292 hasConceptScore W2140901292C2778959862 @default.
• W2140901292 hasConceptScore W2140901292C2779124865 @default.

• next